Stay updated on Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with numerous new resources added related to lung cancer, including links to MedlinePlus and clinical trial information.
    Difference
    3%
    Check dated 2024-11-08T19:21:16.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.0%
    Check dated 2024-11-01T11:43:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T01:28:00.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new study has been added to evaluate investigational agents in combination with pembrolizumab for treating extensive-stage small cell lung cancer, while a previous study focusing on pembrolizumab in combination with investigational agents has been removed.
    Difference
    53%
    Check dated 2024-10-17T20:10:12.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-10-03T05:22:57.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.
    Difference
    0.6%
    Check dated 2024-09-25T23:07:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.